← Return to the plan

Food Production and Integrative Health

ARA6 · Evidence review for team discussion · 27 October 2026

What is supported

Food-processing and monitoring subjects support a practical process test. Therapeutic chemistry cannot substitute for food or health outcomes.

Food manufacturing combines a large employment base, strong concentration and positive recent growth. Growth is slower than its national comparator, so breadth and productivity deserve attention. Retained industry context and the patent observations describe different populations.

Scope and boundary check

The unchanged screen finds 109 narrow and 360 broad current-CPC candidates, versus 99 and 359 at issue. These are overlapping screening counts among utility grants with Arkansas inventors dated 2015–2025, not validated area totals or uncertainty intervals.

Primary-document examples

Decision to take next

Ask a processor to define the product/process, assay, operating constraint and decision a test would change.

Confidence and remaining checks

Source identities, event dates, input hashes and the reviewed technical passages are checked. Area-wide membership remains provisional. Patent ownership, current team readiness, facility/data access, partner demand and commercial outcomes require separate evidence. Low patent counts do not disqualify an area.

Review method: abstract and first independent claim for three purposefully/hash-selected documents per area. This is a bounded analytical review, not a statistical accuracy estimate, external expert sign-off or legal opinion. The seven growth areas and proposed commitments remain in place.